Fundraising Fox

Tetherex Pharmaceuticals Corp

Oklahoma City, US · Founded 2014 · Delaware corporation · 1 known investors

Biotech

Founders & leadership

DF
David FaclonerExecutive Officer
RA
Richard AlvarezExecutive Officer
RM
Rodger McEver, M.D.Director
DK
David KeiserDirector
SR
Scott Rollins, Ph.D.Executive Officer, Director
RR
Russell RotherExecutive Officer
PJ
Philip Jones, M.D.Director
TF
Todd FoleyDirector

Investors · 1

MPM BioImpactreportedBoston · $1M – $15Mvia Todd Foley · board

Reported raises · per SEC filings

Form D private placements
▶Undisclosed amountofferedDec 2020 · 1 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Scott Rollins, Ph.D.Executive Officer, Director
  • Rodger McEver, M.D.Director
  • Richard AlvarezExecutive Officer
  • Scott SamaraDirector
  • Philip Jones, M.D.Director
  • Russell Rother, Ph.D.Executive Officer, Director
  • Todd FoleyDirector
  • David KeiserDirector
  • Jonathan Stocker, Ph.D.Executive Officer
First sale
Dec 2020
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$43MraisedMar 2018 · 240 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip Jones, M.D.Director
  • Rodger McEver, M.D.Director
  • Richard AlvarezExecutive Officer
  • David KeiserDirector
  • David FaclonerExecutive Officer
  • Russell Rother, Ph.D.Executive Officer, Director
  • Scott Rollins, Ph.D.Executive Officer, Director
  • Jonathan Stocker, Ph.D.Executive Officer
  • Todd FoleyDirector
Offering amount
$50M
Amount sold
$43M
Minimum investment
$10K
Proceeds to insiders
$1.2M
First sale
Feb 2018
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$4MraisedOct 2015 · 30 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Philip Jones, M.D.Director
  • Scott Rollins, Ph.D.Executive Officer, Director
  • Todd FoleyDirector
  • Richard AlvarezExecutive Officer
  • David KeiserDirector
  • David FaclonerExecutive Officer
  • Russell RotherExecutive Officer
  • Rodger McEver, M.D.Director
Offering amount
$4M
Amount sold
$4M
Minimum investment
$50K
First sale
May 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b, 05
Full filing on SEC EDGAR ↗
▶$1.3MraisedFeb 2015 · 14 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • David FaclonerExecutive Officer
  • Richard AlvarezExecutive Officer
  • Rodger McEver, M.D.Director
  • David KeiserDirector
  • Scott Rollins, Ph.D.Executive Officer, Director
  • Russell RotherExecutive Officer
  • Philip Jones, M.D.Director
  • Todd FoleyDirector
Offering amount
$1.3M
Amount sold
$1.3M
Minimum investment
$5.3K
First sale
Feb 2015
Incorporated
Corporation, Delaware, 2014
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.